{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA issued guidance on statistical considerations for clinical trials during the COVID-19 public health emergency",
"url": "https://www.lexblog.com/2020/06/19/fda-issued-guidance-on-statistical-considerations-for-clinical-trials-during-the-covid-19-public-health-emergency/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-GG0SCV1X",
"url": "https://www.lexblog.com/lib/GG0SCV1X/"
},
"datePublished": "2020-06-19T13:28:54-04:00",
"dateModified": "2022-07-22T13:51:07-04:00",
"author": {
"@type": "Person",
"name": "John D. Kendzior, Ryan Pate"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Reed Smith LLP"
},
"organizationScope": "at-publication",
"isPartOf": "Health Industry Washington Watch",
"about": "Health Care and Life Sciences",
"sourceUrl": "https://www.healthindustrywashingtonwatch.com/?p=20318",
"sourceStability": "may-move"
}